A Study of Efficacy and Safety of M2951 in Participants With Relapsing Multiple Sclerosis
Clinical trial NCT02975349 · TERMINATED
Trial details
- NCT number
- NCT02975349
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-07
- Primary completion
- 2018-01-24
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.